Suppr超能文献

内脏动脉瘤治疗的单中心经验

Single-Center Experience in the Treatment of Visceral Artery Aneurysms.

作者信息

Martinelli Ombretta, Giglio Alessandra, Irace Luigi, Di Girolamo Alessia, Gossetti Bruno, Gattuso Roberto

机构信息

Department of Vascular Surgery, Policlinico Umberto I°, "Sapienza" University, Rome, Italy.

Department of Vascular Surgery, Policlinico Umberto I°, "Sapienza" University, Rome, Italy.

出版信息

Ann Vasc Surg. 2019 Oct;60:447-454. doi: 10.1016/j.avsg.2019.01.010. Epub 2019 Apr 19.

Abstract

BACKGROUND

Visceral artery aneurysms (VAAs), although rare, represent a life-threatening disease with high mortality rates. With the more frequent use of diagnostic tests, there has been an incidental detection of these lesions which are mostly asymptomatic. It follows that surgeons are increasingly called to decide on the most appropriate management of VAAs between an open surgical or endovascular approach and among the different endovascular options currently available. The aim of this retrospective study was to evaluate the results of open surgery and interventional endovascular strategies of visceral artery aneurysms with respect to technical success, therapy-associated complications, and postinterventional follow-up in the elective and emergency situation.

METHODS

From January 1992 to January 2017, 125 open surgical or endovascular interventions for VAA were performed at our institution. Once the VAA was diagnosed and the indication for treatment was assessed, the preoperative diagnostic work-up consisted of contrast computed tomography (CT) or magnetic resonance imaging (MRI) and, in some patients, digital subtraction angiography. Follow-up included clinical and duplex ultrasound scan (DUS) and contrast-enhanced ultrasound to assess the treated vessel patency and organ perfusion after 1, 6, and 12 months, and yearly thereafter. CT or MRI controls were also performed at 1 year of follow-up and only when DUS was not diagnostic or showed a complication thereafter. After the first 5 years of follow-up, the status of the patient was obtained by a structured telephone survey.

RESULTS

The treatment option was endovascular in 56 of 125 cases (44.8%). Technical success was 98.3%. In one case, the procedure was interrupted for the extensive dissection of the afferent vessel. Twenty-six patients were treated by coil embolization while 29 with covered stenting. The endovascular approach was in emergency in two cases (3.6%). In the endovascular group, mortality was nil. Complications occurred in 5 cases (8.9%): 1 subacute intestinal ischemia caused by superior mesenteric artery dissection, 2 aneurysm reperfusion, 1 stent thrombosis, and 1 massive splenic hematoma. In 69 (55.2%) cases, surgical treatment was preferred, with 24 VAA resections and 45 arterial reconstructions. In 20 cases (29%), open surgery was performed in emergency conditions. In the surgical group, 8 emergency patients (40%) died intraoperatively. The mortality after elective surgical interventions was nil. Complications after surgery were 4 graft late thrombosis (5.8%): asymptomatic in three cases and requiring splenectomy in one.

CONCLUSIONS

There is no overall consensus regarding the indications for treatment of VAA. Currently in emergent setting, the endovascular approach should be considered as the first choice because of its reduced invasiveness, faster way to access and bleeding control; this accounts for the lower morality of the interventional therapy than open surgery. Endovascular approach is effective for elective repair of VAAs, but procedure-related complications may occur in a not negligible number of patients. Given comparable mortality rates and low procedure-related complication rate, surgical approach still has space in the elective management of VAAs, especially for aneurysms unsuitable or challenging for the endovascular option in patients with low surgical risk. The size, location, and morphology of VAAs, systemic or local comorbidities, and specific anatomical situations such as previous abdominal surgery should dictate treatment choice.

摘要

背景

内脏动脉瘤(VAA)虽罕见,但却是一种死亡率很高的危及生命的疾病。随着诊断检查的更频繁使用,这些大多无症状的病变被偶然发现。因此,外科医生越来越多地被要求在开放手术或血管内介入方法以及目前可用的不同血管内选择之间,决定对VAA最合适的治疗方案。这项回顾性研究的目的是评估内脏动脉瘤开放手术和介入性血管内治疗策略在技术成功率、治疗相关并发症以及择期和急诊情况下介入后随访方面的结果。

方法

1992年1月至2017年1月,我们机构对125例VAA进行了开放手术或血管内介入治疗。一旦诊断出VAA并评估了治疗指征,术前诊断检查包括对比计算机断层扫描(CT)或磁共振成像(MRI),在一些患者中还包括数字减影血管造影。随访包括临床检查和双功超声扫描(DUS)以及对比增强超声,以在1、6和12个月以及此后每年评估治疗后血管的通畅情况和器官灌注。在随访1年时以及仅当DUS无法诊断或此后显示有并发症时,也进行CT或MRI检查。在随访的前5年之后,通过结构化电话调查获得患者的状况。

结果

125例病例中有56例(44.8%)选择血管内治疗。技术成功率为98.3%。1例因对输入血管进行广泛解剖而中断手术。26例患者接受了弹簧圈栓塞治疗,29例接受了覆膜支架置入术。血管内介入治疗有2例(3.6%)用于急诊情况。在血管内治疗组中,死亡率为零。发生并发症5例(8.9%):1例因肠系膜上动脉夹层导致亚急性肠缺血,2例动脉瘤再灌注,1例支架血栓形成,1例大量脾血肿。69例(55.2%)病例选择手术治疗,其中24例行VAA切除术,45例行动脉重建术。20例(29%)在急诊情况下进行了开放手术。在手术组中,8例急诊患者(40%)术中死亡。择期手术干预后的死亡率为零。术后并发症为4例移植血管晚期血栓形成(5.8%):3例无症状,1例需要行脾切除术。

结论

关于VAA的治疗指征尚无总体共识。目前在急诊情况下,应将血管内介入方法视为首选,因为其侵入性较小、进入和控制出血更快;这解释了介入治疗比开放手术死亡率更低的原因。血管内介入方法对VAA的择期修复有效,但在相当数量的患者中可能会发生与手术相关的并发症。鉴于死亡率相当且与手术相关的并发症发生率较低,手术方法在VAA的择期治疗中仍有空间,特别是对于手术风险低但不适合或难以采用血管内治疗方案的动脉瘤。VAA的大小、位置和形态、全身或局部合并症以及特定的解剖情况(如既往腹部手术)应决定治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验